Paper26318044
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
Ghilardi C and 7 others. Oncotarget, 2015. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2. Papers, record 26318044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26318044
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Movement | Major topic |
| Endothelial Cells | Major topic |
| Glycoproteins | Major topic |
| Neoplasms | Major topic |
| Trypsin | Major topic |
| Blotting, Western | |
| Cells, Cultured | |
| Epidermal Growth Factor | |
| Fibroblast Growth Factor 2 | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Proteolysis | |
| RNA Interference | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Tumor Microenvironment | |
| Vascular Endothelial Growth Factor A |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17023682 | Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/17023682 | PubMed |
| 2 | 17395884 | Endothelial cell migration during angiogenesis. | Circ Res | 2007 | https://conductscience.org/library/papers/17395884 | PubMed |
| 3 | 9445254 | Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. | Arterioscler Thromb Vasc Biol | 1998 | https://conductscience.org/library/papers/9445254 | PubMed |
| 4 | 15313892 | S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. | Cancer Res | 2004 | https://conductscience.org/library/papers/15313892 | PubMed |
| 5 | 17406981 | Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level. | Neurochem Res | 2007 | https://conductscience.org/library/papers/17406981 | PubMed |
| 6 | 20035377 | Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20035377 | PubMed |
| 7 | 17480209 | Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N-terminal leucine. A possible means to regulate gene expression. | FEBS J | 2007 | https://conductscience.org/library/papers/17480209 | PubMed |
| 8 | 8294000 | Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. | Gene | 1993 | https://conductscience.org/library/papers/8294000 | PubMed |
| 9 | 23258495 | PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. | Mol Cancer Res | 2012 | https://conductscience.org/library/papers/23258495 | PubMed |
| 10 | 16029158 | Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. | Protein Pept Lett | 2005 | https://conductscience.org/library/papers/16029158 | PubMed |
| 11 | 17851543 | Emerging roles of proteases in tumour suppression. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/17851543 | PubMed |
| 12 | 22130514 | Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/22130514 | PubMed |
| 13 | 25593998 | Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer. | Oncoscience | 2014 | https://conductscience.org/library/papers/25593998 | PubMed |
| 14 | 16457812 | Trypsins and their role in carcinoma growth. | Exp Cell Res | 2006 | https://conductscience.org/library/papers/16457812 | PubMed |
| 15 | 15723303 | Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. | Int J Cancer | 2005 | https://conductscience.org/library/papers/15723303 | PubMed |
| 16 | 17138934 | Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17138934 | PubMed |
| 17 | 12947001 | Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2. | Blood | 2003 | https://conductscience.org/library/papers/12947001 | PubMed |
| 18 | 18000791 | The role of tissue factor pathway inhibitor-2 in cancer biology. | Semin Thromb Hemost | 2007 | https://conductscience.org/library/papers/18000791 | PubMed |
| 19 | 24049668 | Biochemical and structural insights into mesotrypsin: an unusual human trypsin. | Int J Biochem Mol Biol | 2013 | https://conductscience.org/library/papers/24049668 | PubMed |
| 20 | 17372906 | Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas. | Int J Cancer | 2007 | https://conductscience.org/library/papers/17372906 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41163337 | CpG Methylation-Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis. | Cancer Sci | 2026 | https://conductscience.org/library/papers/41163337 | PubMed |
| 37250150 | UHRF1/DNMT1-MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37250150 | PubMed |
| 35480112 | CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35480112 | PubMed |
| 33207594 | Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33207594 | PubMed |
| 30829570 | A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing. | Elife | 2019 | https://conductscience.org/library/papers/30829570 | PubMed |
| 30755669 | PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma. | Sci Rep | 2019 | https://conductscience.org/library/papers/30755669 | PubMed |
| 29629340 | Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines. | Front Cell Infect Microbiol | 2018 | https://conductscience.org/library/papers/29629340 | PubMed |
| 28844099 | Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma. | J Mol Med (Berl) | 2017 | https://conductscience.org/library/papers/28844099 | PubMed |
| 28463992 | Small molecule inhibitors of mesotrypsin from a structure-based docking screen. | PLoS One | 2017 | https://conductscience.org/library/papers/28463992 | PubMed |
| 26957636 | Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy. | Biochem J | 2016 | https://conductscience.org/library/papers/26957636 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26318044
GET https://conductscience.org/api/papers/v1/26318044/references?page=2